Protein C Antigen Is Not an Acute Phase Reactant and Is often High in Ischemic Heart Disease and Diabetes

Summary

Protein C, an antithrombotic protein, was measured immunologically in 299 patients with clinical conditions associated with a high frequency of venous or arterial thromboembolism. The mean protein C antigen (PC: Ag) level was high for 48 patients with ischemic heart disease and, to a lesser extent, for 95 diabetics. In 28 patients with thrombotic strokes, 48 patients with proximal deep-vein thrombosis and in 80 patients with localized or metastatic tumors, mean PC: Ag was normal. Comparison of the pattern of changes of PC: Ag levels with those of fibrinogen, orosomucoid and prothrombin in 21 patients during the postoperative period and in 20 patients with active rheumatoid arthritis ruled out the possibility that high PC: Ag is non-specific, acute-phase reaction to inflammation, tissue injury or neoplastic growth. Therefore, high PC:Ag might be specifically related to the thrombotic tendency of these patients, but the mechanism of such a relationship remains to be clarified.

Key words

Protein C - Deep-vein thrombosis - Tumors - Stroke-diabetes - Ischemic heart disease - Acute phase reactions

• References

• 1 Stenflo JA. A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization J Biol Chem 1976; 251: 355-363
• 2 Esmon CT, Stenflo JA, Suttie JW, Jackson CM. A new vitamin K-dependent protein. A phospholipid binding zymogen of a serine protease J Biol Chem 1976; 251: 3052-3056
• 3 Kiesel W, Canfield W, Ericsson L, Davie EW. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977; 16: 5824-5831
• 4 Kiesel W. Human protein C. Isolation, characterization and mechanism of activation by α-thrombin J Clin Invest 1979; 64: 761-769
• 5 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249-2252
• 6 Marlar RA, Kleiss AJ, Griffin JM. Human protein C: inactivation of factors V and VIII in plasma by activated molecule. Ann NY Acad Sci 1981; 370: 303-310
• 7 Comp PC, Esmon CT. Activated protein C inhibits platelet prothrombin converting activity. Blood 1979; 54: 1272-1281
• 8 Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221-1228
• 9 Griffin JM, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
• 10 Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism: a study of three Dutch families. N Engl J Med 1981; 309: 340-344
• 11 Branson HE, Marble R, Griffin JM. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 1983; 2: 1165-1167
• 12 Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559-562
• 13 Griffin JM, Mosher DF, Zimmerman TS, Kleiss AJ. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 1982; 60: 261-264
• 14 Mannucci PM, Viganò S. Deficiencies of protein C, an inhibitor of blood coagulation. Lancet 1982; 2: 463-467
• 15 D’Angelo A, Micossi P, Mannucci PM, Garimberti B, Franchi F, Pozza G. Increased production of platelet thromboxane B₂ in noninsulin dependent diabetes. Relationship to vascular complications Eur J Clin Invest 1984; 14: 83-86
• 16 Kushner I, Gewurz H, Benson MD. C-reactive protein and the acute-phase response. J Lab Clin Med 1981; 97: 739-749
• 17 Bern MM, Klumpart DI, Wheeler WE, Davis GL. Factor VIII complex in chronic renal failure: influence of protein C, fibrinolysis and diabetes mellitus. Thromb Res 1983; 31: 177-186
• 18 Davies JA, McNicol GP. Detection of a prethrombotic state. Haemostasis and Thrombosis. Bloom A, Thomas DP. (eds) Churchill Livingstone; Edinburgh, London: 1981. pp 593-609
• 19 Editorial. Hemostatic factors and coronary heart disease. Lancet 1981; 1: 23-24
• 20 Jones RL, Peterson CM. Hematologic alterations in diabetes mellitus. Am J Med 1981; 70: 339-352
• 21 Hirsh J. Laboratory diagnosis of thrombosis. In: Hemostasis and Thrombosis. Basic principles and clinical practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds) J B Lippincott Company; Philadelphia: 1982. pp 789-830
• 22 Comp PC, Nixon RR, Esmon CT. Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood 1984; 63: 15-21
• 23 Sala N, Owen WG, Collen D. A functional assay of protein C in human plasma. Blood 1984; 63: 671-675
• 24 Bertina RM, Broekmans AW, Krommenhoek van Es T, van Wijngaarden A. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemostas 1984; 51: 1-5
• 25 Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization J Biol Chem 1983; 285: 163-168